Applied Proteomics Raises $22.5M

San Diego-based Applied Proteomics, which is developing personalized medicine applications, said today that it has raised $22.5M in a Series B funding, and moved its headquarters to San Diego. The funding came from Domain Associates, Vulcan Capital, and angel investors. As part of the funding, the firm said that Domain's James C. Blair joins the company's board. Applied Proteomics was co-founded by David Agus, who is director of the USC Center for Applied Molecular Medicine and the USC Westside Cancer Center. The firm's other co-founder is W. Daniel Hillis of Applied Minds, and who is also a professor at USC's Keck School of Medicine. As part of the funding, the company also said it has appointed Pter Klemm, Ph.D. as its Chief Executive Officer. Klemm is Chairman of Pathwork Diagnostics, and previously served as CEO and president of Predictive Biosciences and CEO of GeneOhm Sciences. More information »